Skip to main content
Discovering the causes of cancer and the means of prevention
 

Current Fellows in the Laboratory of Translational Genomics

Meet the fellows in the Laboratory of Translational Genomics (LTG) and learn about their work.

Laufey Amundadottir Lab

  • Ehssan Abdolalizadeh, B.A.Sc.

    Mr. Abdolalizadeh, postbaccalaureate fellow in LTG, investigates the mechanisms underlying the pancreatic cancer risk signals at chr1p36.33 and chr7p14.1. His mentor is Laufey Amundadottir, Ph.D.

  • Erin Char, B.A.

    Ms. Char, postbaccalaureate fellow in LTG, analyzes paired transcriptomic and epigenomic data of purified cell types from normal pancreatic tissue and characterizes the functional implications of a pancreatic cancer GWAS signal at the promoter of PDX1 on chr13q12.2. Her mentor is Jason Hoskins, Ph.D.

  • Aidan O’Brien, M.Pharm., M.Sc.

    Mr. O'Brien, predoctoral fellow in LTG, studies the functional characterization of susceptibility variants identified through genome-wide association studies and the identification of novel non-coding driver mutations in pancreatic cancer. His mentor is Laufey Amundadottir, Ph.D.

  • Jun Zhong, Ph.D.

    Dr. Zhong, postdoctoral fellow in LTG, focuses his research on identifying inherited variants associated with risk of pancreatic cancer using various genome-wide approaches, understanding the biology of germline risk variants using genomic technologies, and identifying non-coding somatic mutations that drive pancreatic carcinogenesis. His mentor is Laufey Amundadottir, Ph.D.

Kevin Brown Lab

  • Karen Funderburk, M.S.

    Ms. Funderburk, postbaccalaureate fellow in LTG, uses bioinformatic tools to identify functional variants of melanoma and lung cancer risk loci reported in genome-wide association studies. Her mentors are Kevin Brown, Ph.D., and Jiyeon Choi, Ph.D., M.S. (co-mentor).

  • Rebecca Hennessey, Ph.D.

    Dr. Hennessey, postdoctoral fellow in LTG, utilizes screening methods to functionally characterize multiple and complex melanoma susceptibility loci that were identified via genome-wide association studies. Her mentor is Kevin Brown, Ph.D.

  • Hyunkyung Kong, Ph.D.

    Dr. Kong, postdoctoral fellow in LTG, performs functional characterization of susceptibility variants identified by genome-wide association studies, and how they influence the risk of melanoma. Her mentor is Kevin Brown, Ph.D.

  • Hayley A. Sowards, B.S.

    Ms. Sowards, postbaccalaureate fellow in LTG, performs functional analysis loci associated with melanoma in familial and genome-wide association studies. Her mentor is Kevin Brown, Ph.D.

  • Rohit Thakur, Ph.D.

    Dr. Thakur, postdoctoral fellow in LTG, performs integrative genomic analyses of melanocyte and melanoma genomic and epigenomic datasets to understand genes, molecular mechanisms, and environmental interactions underlying melanoma susceptibility. His mentors are Kevin M. Brown, Ph.D., and Mitchell Machiela, Sc.D., M.P.H.

Jiyeon Choi Lab

  • Alyxandra Golden, B.A.

    Ms. Golden, postbaccalaureate fellow in LTG, performs functional characterization of associated risk loci for lung cancer. Her mentor is Jiyeon Choi, Ph.D., M.S.

  • James Feng, B.S.

    Mr. Feng, postbaccalaureate fellow in LTG, studies genetic susceptibility to melanoma and lung cancer through functional characterization of risk loci reported in genome-wide association studies. His mentor is Jiyeon Choi, Ph.D., M.S.

  • Erping Long, M.D., Ph.D.

    Dr. Long, postdoctoral fellow in LTG, conducts research that leverages computational approaches and large-scale functional genomics resources to understand genetic susceptibility to lung cancer and melanoma. His mentor is Jiyeon Choi, Ph.D., M.S.

  • Harsh Patel, Ph.D.

    Dr. Patel, postdoctoral fellow in LTG, works on functional characterization of the genes and molecular pathways associated with genetic variants that contribute to risk of melanoma and lung cancer development. His mentor is Jiyeon Choi, Ph.D., M.S.

Michael Dean Lab

  • Nina Rao, B.S.

    Ms. Rao, predoctoral fellow in LTG, studies genetics and molecular epidemiology of bladder cancer, currently focusing on factors affecting APOBEC mutagenesis. Her mentor is Michael Dean, Ph.D.

  • Nicole Rossi, B.S.

    Ms. Rossi, postbaccalaureate fellow in LTG, studies the implications of human papillomavirus (HPV) infection in promotion of tumorigenesis and evasion of immune therapies, utilizing a variety of genetic tools and techniques. Her mentor is Michael Dean, Ph.D.

Ludmila Prokunina-Olsson Lab

  • Francine S. Baker, M.S.

    Ms. Baker, postbaccalaureate fellow and iCURE scholar in LTG, explores the connection between Epstein Barr virus (EBV) infection and IFNL4, and its relation to health disparity. Her mentors are Ludmila Prokunina-Olsson, Ph.D., and Sam Mbulaiteye, MBChB, M.Phil., M.Med., Infections and Immunoepidemiology Branch.

  • Abdul Rouf Banday, Ph.D.

    Dr. Banday, research fellow in LTG, uses computational and laboratory methods to explore underlying molecular mechanisms of genetic signals identified by genome-wide association studies for bladder cancer. His mentor is Ludmila Prokunina-Olsson, Ph.D.

  • Oscar Florez-Vargas, Ph.D., M.Sc.

    Dr. Florez-Vargas, postdoctoral fellow in LTG, is studying multiple genomic regions that have been associated via genome-wide association studies with increased risk of several cancers. His mentor is Ludmila Prokunina-Olsson, Ph.D.

  • Michelle Ho, Ph.D.

    Dr. Ho, postdoctoral fellow in LTG, is using CRISPR-based methods to screen genetic risk variants and functionally characterize their relationships to bladder cancer development. Her mentor is Ludmila Prokunina-Olsson, Ph.D.

  • Brenen Papenberg, Ph.D.

    Dr. Papenberg, postdoctoral fellow in LTG, uses computational and laboratory methods to investigate several genomic regions that are associated with increased risk of bladder cancer. His mentor is Ludmila Prokunina-Olsson, Ph.D.

  • Timothy Ring, B.S.

    Mr. Ring, postbaccalaureate fellow in LTG, conducts CRISPR-based research into liver cancer as well as working to better characterize the novel interferon IFNL4 and its roles in chronic infection and cancer development. His mentor is Ludmila Prokunina-Olsson, Ph.D.